glp 1 gip dual agonist mechanism of action Understand GLP-1/GIP Tirzepatide and Its Effect on Current Weight Loss Therapy TIRZEPATIDE Mechanism of action of

These include SGLT2 inhibitors, optimised insulin regimens, structured education programs and targeted lifestyle support

Unlike other large-scale real-world studies such as SUSTAIN-6, LEADER, and REWIND [30], which treat DR as a secondary outcome rather than a primary outcome, these three studies directly set DR occurrence as the outcome while conducting retrospective analyses using large-scale cohort studies, thereby enabling a more precise assessment of the relationship between GLP-1RAs and DR

The answer depends on the study, dose, population, treatment length, and whether the medication is approved or investigational

Standardised measures were used to identify cases to minimise documentation errors

For this reason, they are referred to as prandial GLP-1 receptor agonists